SMAD4 and neoplasm: The loss of SMAD4 leads to extensive signaling alterations in PDAC cells, including the disruption of TGFβ-induced cell cycle arrest, enhanced tumor cell migration, and reduced chemo- and radiosensitivity [22,27,28,29,30,31].